Avenue (ATXI) Gains 5.28% on August 5

Equities Staff  |

Avenue Therapeutics Inc (NASDAQ: ATXI) has climbed $0.0138 (5.28%) and sits at $0.28, as of 11:46:51 est on August 5.

45,209 shares have exchanged hands.

The Company is up 5.49% over the last 5 days and shares gained 4.88% over the last 30 days.

Avenue anticipates its next earnings on 2022-08-15.

For technical charts, analysis, and more on Avenue visit the company profile.

About Avenue Therapeutics Inc

Avenue Therapeutics is a specialty pharmaceutical company whose mission is to develop IV tramadol, a potential alternative that could reduce the use of conventional opioids, for patients suffering from acute pain in the U.S. Avenue is headquartered in New York City and was founded by Fortress Biotech, Inc.

To get more information on Avenue Therapeutics Inc and to follow the company's latest updates, you can visit the company's profile page here: Avenue Therapeutics Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Trending Articles

These Stocks are Sending a Signal (like Amazon in 2008)
It Isn’t a Recession Until This Group of Economists Says So
What You Should Know About Europe's Energy Wars
Meatless Meats and Smokeless Smokes
Mixed Wireless Recovery at AT&T, Verizon, T-Mobile: Jeff Kagan
The Strong Dollar Is a Problem for Stocks

Market Movers

Sponsored Financial Content